Namrata Patel - Haleon Plc Chief Officer
HLN Stock | USD 8.47 0.00 0.00% |
Executive
Namrata Patel is Chief Officer of Haleon plc
Age | 58 |
Address | The Heights, Weybridge, United Kingdom, KT13 0NY |
Phone | 44 1932 822000 |
Web | https://www.haleon.com |
Haleon Plc Management Efficiency
The company has Return on Asset of 0.0428 % which means that on every $100 spent on assets, it made $0.0428 of profit. This is way below average. In the same way, it shows a return on shareholders' equity (ROE) of 0.067 %, implying that it generated $0.067 on every 100 dollars invested. Haleon Plc's management efficiency ratios could be used to measure how well Haleon Plc manages its routine affairs as well as how well it operates its assets and liabilities. As of the 29th of April 2024, Return On Tangible Assets is likely to drop to 0.12. In addition to that, Return On Capital Employed is likely to drop to 0.04. At this time, Haleon Plc's Non Current Assets Total are very stable compared to the past year. As of the 29th of April 2024, Non Currrent Assets Other is likely to grow to about 157.5 M, while Total Assets are likely to drop about 27.7 B.Similar Executives
Showing other executives | EXECUTIVE Age | ||
Graham Jackson | Bausch Health Companies | N/A | |
Ramkumar Rayapureddy | Viatris | N/A | |
Michelle Pepin | Emergent Biosolutions | N/A | |
Matthew Abernethy | Neurocrine Biosciences | 44 | |
Julie Cooke | Neurocrine Biosciences | 58 | |
Tokumasa Takeda | Takeda Pharmaceutical Co | N/A | |
Selina Zhang | HUTCHMED DRC | N/A | |
Eric Benevich | Neurocrine Biosciences | 59 | |
Vivek Mittal | Dr Reddys Laboratories | N/A | |
Ingrid Delaet | Neurocrine Biosciences | 57 | |
John Pearson | PetIQ Inc | N/A | |
Jane Sorensen | Neurocrine Biosciences | N/A | |
Kedar Upadhye | Dr Reddys Laboratories | N/A | |
Ken Araki | Takeda Pharmaceutical Co | N/A | |
Theodora Mistras | Viatris | N/A | |
Donald Pearl | Bausch Health Companies | N/A | |
Jennifer Mauer | Viatris | N/A | |
Kelly Warfield | Emergent Biosolutions | N/A | |
David Boyer | Neurocrine Biosciences | 44 | |
Jiny MBA | Bausch Health Companies | 47 | |
Mwana Lugogo | Takeda Pharmaceutical Co | 54 |
Management Performance
Return On Equity | 0.067 | ||||
Return On Asset | 0.0428 |
Haleon plc Leadership Team
Elected by the shareholders, the Haleon Plc's board of directors comprises two types of representatives: Haleon Plc inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Haleon. The board's role is to monitor Haleon Plc's management team and ensure that shareholders' interests are well served. Haleon Plc's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Haleon Plc's outside directors are responsible for providing unbiased perspectives on the board's policies.
Keith Choy, President Pacific | ||
Tamara Rogers, Chief Officer | ||
Lisa Paley, President America | ||
Brian McNamara, CEO Director | ||
Bjarne Tellmann, General Counsel | ||
Bart Derde, Head Chain | ||
Franck Riot, Chief Officer | ||
Bjorn Timelin, Head Strategy | ||
Tobias Hestler, CFO Director | ||
Amy Landucci, Head Technology | ||
Namrata Patel, Chief Officer | ||
Jooyong Lee, Head CEO | ||
Mairead Nayager, Chief Officer | ||
Teri Lyng, Head Sustainability | ||
Sonya Ghobrial, Head Relations | ||
Ed Petter, Chief Officer | ||
Filippo Lanzi, President LatAm |
Haleon Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Haleon Plc a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
Return On Equity | 0.067 | ||||
Return On Asset | 0.0428 | ||||
Profit Margin | 0.09 % | ||||
Operating Margin | 0.20 % | ||||
Current Valuation | 86.72 B | ||||
Shares Outstanding | 4.57 B | ||||
Shares Owned By Insiders | 4.33 % | ||||
Shares Owned By Institutions | 8.77 % | ||||
Number Of Shares Shorted | 23.97 M | ||||
Price To Earning | 18.06 X |
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ArchitectCheck out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in Haleon plc. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in bureau of economic analysis. To learn how to invest in Haleon Stock, please use our How to Invest in Haleon Plc guide.You can also try the Portfolio Diagnostics module to use generated alerts and portfolio events aggregator to diagnose current holdings.
Complementary Tools for Haleon Stock analysis
When running Haleon Plc's price analysis, check to measure Haleon Plc's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Haleon Plc is operating at the current time. Most of Haleon Plc's value examination focuses on studying past and present price action to predict the probability of Haleon Plc's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Haleon Plc's price. Additionally, you may evaluate how the addition of Haleon Plc to your portfolios can decrease your overall portfolio volatility.
Piotroski F Score Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals | |
Idea Analyzer Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas | |
Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
Portfolio Diagnostics Use generated alerts and portfolio events aggregator to diagnose current holdings | |
Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital | |
Fundamental Analysis View fundamental data based on most recent published financial statements | |
Money Managers Screen money managers from public funds and ETFs managed around the world | |
Investing Opportunities Build portfolios using our predefined set of ideas and optimize them against your investing preferences |
Is Haleon Plc's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Haleon Plc. If investors know Haleon will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Haleon Plc listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth 0.051 | Dividend Share 0.06 | Earnings Share 0.28 | Revenue Per Share 2.448 | Quarterly Revenue Growth (0) |
The market value of Haleon plc is measured differently than its book value, which is the value of Haleon that is recorded on the company's balance sheet. Investors also form their own opinion of Haleon Plc's value that differs from its market value or its book value, called intrinsic value, which is Haleon Plc's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Haleon Plc's market value can be influenced by many factors that don't directly affect Haleon Plc's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Haleon Plc's value and its price as these two are different measures arrived at by different means. Investors typically determine if Haleon Plc is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Haleon Plc's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.